Onderneming Chong Kun Dang Pharmaceutical Corp.
Aandelen
A185750
KR7185750007
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
103.100 KRW | +1,18% | -1,15% | -21,24% |
Vakgebied
Aantal werknemers: 2 291
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 1 488 345 | 100,0 % | 1 669 404 | 100,0 % | +12,17% |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
South Korea
89,4
%
| 1 423 245 | 95,6 % | 1 493 073 | 89,4 % | +4,91% |
Switzerland
6,4
%
| - | - | 106 064 | 6,4 % | - |
Japan
2,5
%
| 45 891 | 3,1 % | 41 157 | 2,5 % | -10,32% |
Others
1,7
%
| 8 626 | 0,6 % | 29 110 | 1,7 % | +237,46% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Young-Ju Kim
CEO | Chief Executive Officer | 60 | 20-03-15 |
Jong-Rae Lim
CTO | Chief Tech/Sci/R&D Officer | 57 | - |
Ja-Min Gu
BRD | Director/Board Member | 60 | - |
Chang-Gyu Kim
BRD | Director/Board Member | 68 | - |
Jong-Han Park
PRN | Corporate Officer/Principal | 61 | - |
Ho-Seong Yoo
PRN | Corporate Officer/Principal | 64 | - |
Yeo-Wook Go
PRN | Corporate Officer/Principal | 61 | - |
Hong-Soon Park
PRN | Corporate Officer/Principal | 68 | - |
Jong-Han Kang
SAM | Sales & Marketing | 57 | - |
Dae-Gil Bae
PRN | Corporate Officer/Principal | 61 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chang-Gyu Kim
BRD | Director/Board Member | 68 | - |
Seong-Gon Kim
BRD | Director/Board Member | 62 | - |
Ja-Min Gu
BRD | Director/Board Member | 60 | - |
Young-Ju Kim
CEO | Chief Executive Officer | 60 | 20-03-15 |
Ki-Won Kim
BRD | Director/Board Member | 59 | - |
Soon-Wook Hong
BRD | Director/Board Member | 68 | 15-03-19 |
In-Soo Kang
BRD | Director/Board Member | 63 | 15-03-19 |
Dong-Shin Chang
BRD | Director/Board Member | 55 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 13 174 420 | 6 908 366 ( 52,44 %) | 471 810 ( 3,581 %) | 52,44 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
381 024 | 2.89% | 31 189 485 $ |
Bedrijfsgegevens
Chong Kun Dang Pharmaceutical Corp.
8 Chungjeong-ro Seondaemun-gu
03742, Seoul
+
http://www.ckdpharm.comSector
Verkoop per regio
Herzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-21,24% | 969 mln. | |
+20,50% | 43,57 mld. | |
+20,70% | 22,7 mld. | |
+15,82% | 14,32 mld. | |
+11,20% | 13,42 mld. | |
+44,94% | 11,83 mld. | |
-8,84% | 6,98 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+12,33% | 5,51 mld. |
- Beurs
- Aandelen
- Koers A185750
- Onderneming Chong Kun Dang Pharmaceutical Corp.